Skip to main page content
U.S. flag

An official website of the United States government

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Search Results

320 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
New radiopharmaceuticals for receptor scintigraphy and radionuclide therapy.
Virgolini I, Traub T, Leimer M, Novotny C, Pangerl T, Ofluoglu S, Halvadjieva E, Smith-Jones P, Flores J, Li SR, Angelberger P, Havlik E, Andreae F, Raderer M, Kurtaran A, Niederle B, Dudczak R. Virgolini I, et al. Q J Nucl Med. 2000 Mar;44(1):50-8. Q J Nucl Med. 2000. PMID: 10932601 Review.
Absence of therapeutic efficacy of the somatostatin analogue lanreotide in advanced primary hepatic cholangiocellular cancer and adenocarcinoma of the gallbladder despite in vivo somatostatin-receptor expression.
Fiebiger WC, Scheithauer W, Traub T, Kurtaran A, Gedlicka C, Kornek GV, Virgolini I, Raderer M. Fiebiger WC, et al. Among authors: virgolini i. Scand J Gastroenterol. 2002 Feb;37(2):222-5. doi: 10.1080/003655202753416911. Scand J Gastroenterol. 2002. PMID: 11843061 Clinical Trial.
Somatostatin-receptor scintigraphy for staging and follow-up of patients with extraintestinal marginal zone B-cell lymphoma of the mucosa associated lymphoid tissue (MALT)-type.
Raderer M, Traub T, Formanek M, Virgolini I, Osterreicher C, Fiebiger W, Penz M, Jäger U, Pont J, Chott A, Kurtaran A. Raderer M, et al. Among authors: virgolini i. Br J Cancer. 2001 Nov 16;85(10):1462-6. doi: 10.1054/bjoc.2001.2070. Br J Cancer. 2001. PMID: 11720429 Free PMC article. Clinical Trial.
Comparative somatostatin receptor scintigraphy using in-111-DOTA-lanreotide and in-111-DOTA-Tyr3-octreotide versus F-18-FDG-PET for evaluation of somatostatin receptor-mediated radionuclide therapy.
Virgolini I, Patri P, Novotny C, Traub T, Leimer M, Füger B, Li SR, Angelberger P, Raderer M, Wogritsch S, Kurtaran A, Kletter K, Dudczak R. Virgolini I, et al. Ann Oncol. 2001;12 Suppl 2:S41-5. doi: 10.1093/annonc/12.suppl_2.s41. Ann Oncol. 2001. PMID: 11762351 Free article.
Experience with indium-111 and yttrium-90-labeled somatostatin analogs.
Virgolini I, Traub T, Novotny C, Leimer M, Füger B, Li SR, Patri P, Pangerl T, Angelberger P, Raderer M, Burggasser G, Andreae F, Kurtaran A, Dudczak R. Virgolini I, et al. Curr Pharm Des. 2002;8(20):1781-807. doi: 10.2174/1381612023393756. Curr Pharm Des. 2002. PMID: 12171531 Review.
320 results